Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-093111
Filing Date
2025-07-02
Accepted
2025-07-02 16:46:45
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4529
  Complete submission text file 0000950170-25-093111.txt   6283
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address
Kiselak Tomas (Reporting) CIK: 0001830177 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 251102023